Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations. - Wikidata - wikimedia - TriplyDB

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

http://www.wikidata.org/entity/Q37124169

about

Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis.Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.

P2860

Q34406177-D4D74D2E-B618-4EE6-8DFE-BAF0ECEBD4A2 Q38217723-41A5A0E7-750C-45E0-AD84-71674B7A7539

P2860

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

http://www.wikidata.org/entity/Q37124169

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunoactivating peptide p4 au ...... two diverse human populations.

@en

Immunoactivating peptide p4 au ...... two diverse human populations.

@nl

type

label

Immunoactivating peptide p4 au ...... two diverse human populations.

@en

Immunoactivating peptide p4 au ...... two diverse human populations.

@nl

prefLabel

Immunoactivating peptide p4 au ...... two diverse human populations.

@en

Immunoactivating peptide p4 au ...... two diverse human populations.

@nl

P1433

Q37124169-48BE508F-B2A8-44C3-B812-3600389B616E

P1476

Q37124169-C525A56A-F84D-4462-8276-F5154A85E059

P2093

Q37124169-03034843-DB0C-439D-8CE1-0D081B41B54C

Q37124169-0F74BCAB-7C4C-4661-84B2-8E10CF628C00

Q37124169-180C3DB3-41AA-4B1D-8D52-B225824F243D

Q37124169-19BCAB21-636D-492A-8EA9-88E273038BF7

Q37124169-3990849D-8EEC-4243-8B0D-565D27E1314F

Q37124169-3BDAD509-DCD1-4B94-8623-9D01758A881D

Q37124169-55F8E5F4-B45C-456B-B78C-6100DAA834B4

Q37124169-60EAEB58-A29E-4397-884D-959079C9968C

Q37124169-705D53F0-EA53-44BA-83AB-75B5C79E9DF1

Q37124169-7C0AE099-4AED-4ECB-A0B6-E7B1C29A20A1

P2860

Q37124169-4513B770-3237-40D1-A0EF-FBD310F3B1BA

Q37124169-59002205-12E2-47C9-ACE8-649CE52DA908

Q37124169-6875B57F-3AEA-44B5-A2B6-AA45486A958F

Q37124169-A643640F-9012-4119-8B7A-067A826890FC

Q37124169-A6694DB8-2519-436A-9929-CBC290863FE0

Q37124169-E7142A95-9B84-454E-AD93-D983C5A27927

Q37124169-EDF12DF9-61B3-4100-A541-6CCDD85196E9

Q37124169-F31CDADC-6E2B-4138-BBCB-47BF70282423

P304

Q37124169-2B17C042-DEBD-4FA2-ABE1-D99B38E10ACC

P31

Q37124169-591387C9-8C77-49DF-B5D1-DDC996BB560E

P356

Q37124169-3C522246-C932-4122-B166-CDAE5ACEF747

P407

Q37124169-17C21EF9-99CE-4F86-A052-007F0A51E8D8

P433

Q37124169-CA16A99F-C1DB-4E9F-8A8B-404600E6DB9F

P478

Q37124169-366B94FC-B849-4396-A6A8-EE968A10DAFF

P577

Q37124169-501E1110-9FB5-46F3-8E03-429EDF1DC653

P5875

Q37124169-281D4522-52F2-4875-BDD2-3FDBB8034AF5

P698

Q37124169-F7EC369B-275B-4503-BB08-370A5A85AF04

P921

Q37124169-019C0891-AA7E-41FB-AD38-9D0D28324182

Q37124169-77D24DC2-F69D-4539-8590-83414092B6DF

P932

Q37124169-46C96D56-1DFE-4A93-9330-68D07A0FC625

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Immunoactivating peptide p4 au ...... two diverse human populations.

@en

P2093

Adam K Wright

http://www.w3.org/2001/XMLSchema#string

Angela D Wright

http://www.w3.org/2001/XMLSchema#string

Aras Kadioglu

http://www.w3.org/2001/XMLSchema#string

Edwin W Ades

http://www.w3.org/2001/XMLSchema#string

George M Carlone

http://www.w3.org/2001/XMLSchema#string

Gowrisankar Rajam

http://www.w3.org/2001/XMLSchema#string

Jacquelyn S Sampson

http://www.w3.org/2001/XMLSchema#string

Jamie Rylance

http://www.w3.org/2001/XMLSchema#string

Mathieu Bangert

http://www.w3.org/2001/XMLSchema#string

Matthew J Kelly

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia.

Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.

P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.

Wood smoke exposure, poverty and impaired lung function in Malawian adults.

P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.

A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection.

A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization.

P304

4566-4569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00742-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

244481136

http://www.w3.org/2001/XMLSchema#string

P698

23817378

http://www.w3.org/2001/XMLSchema#string

P921

P932

3754341

http://www.w3.org/2001/XMLSchema#string